drugset / Trial / NCT01670773

A Study of CAT-1004 Biomarkers in Healthy Subjects

NCT01670773

Phase 1 Completed 9 enrolled Catabasis Pharmaceuticals
RandomizedCrossoverSingle-blindBasic science

Summary

This study is being conducted to assess mechanistic blood biomarkers of CAT-1004 in healthy humans.

Timeline

Start
2012-08
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator DHA Unknown
Subject Edasalonexent Small molecule
Comparator Salsalate Small molecule

Indications

No indication recorded.